Clinical Trial: Efficacy and Safety of XH02 for the Treatment of Hypoparathyroidism

U.S., Sept. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07197450) titled 'Efficacy and Safety of XH02 for the Treatment of Hypoparathyroidism' on Sept. 14.

Brief Summary: This study aims to evaluate the safety and efficacy of a novel PTH replacement therapy drug in patients with hypoparathyroidism. The drug is an mRNA drug which will be translated into PTH after intravenous administration, to achieve the therapeutic effect.

Study Start Date: May 20

Study Type: INTERVENTIONAL

Condition: Hypoparathyroidism

Intervention: DRUG: intravenous administration of PTH1-84 mRNA

intravenous administration of PTH1-84 mRNA

Recruitment Status: RECRUITING

Sponsor: Peking Union Medical College Hospital

Published...